Literature DB >> 29170536

Non-coding RNA networks in cancer.

Eleni Anastasiadou1, Leni S Jacob1, Frank J Slack1.   

Abstract

Thousands of unique non-coding RNA (ncRNA) sequences exist within cells. Work from the past decade has altered our perception of ncRNAs from 'junk' transcriptional products to functional regulatory molecules that mediate cellular processes including chromatin remodelling, transcription, post-transcriptional modifications and signal transduction. The networks in which ncRNAs engage can influence numerous molecular targets to drive specific cell biological responses and fates. Consequently, ncRNAs act as key regulators of physiological programmes in developmental and disease contexts. Particularly relevant in cancer, ncRNAs have been identified as oncogenic drivers and tumour suppressors in every major cancer type. Thus, a deeper understanding of the complex networks of interactions that ncRNAs coordinate would provide a unique opportunity to design better therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29170536      PMCID: PMC6337726          DOI: 10.1038/nrc.2017.99

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  161 in total

1.  A nucleolar protein, H19 opposite tumor suppressor (HOTS), is a tumor growth inhibitor encoded by a human imprinted H19 antisense transcript.

Authors:  Patrick Onyango; Andrew P Feinberg
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-21       Impact factor: 11.205

2.  ADARs Edit MicroRNAs to Promote Leukemic Stem Cell Activity.

Authors:  Wen Cai Zhang; Frank J Slack
Journal:  Cell Stem Cell       Date:  2016-08-04       Impact factor: 24.633

3.  Oncogenic Role of Fusion-circRNAs Derived from Cancer-Associated Chromosomal Translocations.

Authors:  Jlenia Guarnerio; Marco Bezzi; Jong Cheol Jeong; Stella V Paffenholz; Kelsey Berry; Matteo M Naldini; Francesco Lo-Coco; Yvonne Tay; Andrew H Beck; Pier Paolo Pandolfi
Journal:  Cell       Date:  2016-08-11       Impact factor: 41.582

4.  Formation of triple-helical structures by the 3'-end sequences of MALAT1 and MENβ noncoding RNAs.

Authors:  Jessica A Brown; Max L Valenstein; Therese A Yario; Kazimierz T Tycowski; Joan A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-05       Impact factor: 11.205

5.  ADAR1 Activation Drives Leukemia Stem Cell Self-Renewal by Impairing Let-7 Biogenesis.

Authors:  Maria Anna Zipeto; Angela C Court; Anil Sadarangani; Nathaniel P Delos Santos; Larisa Balaian; Hye-Jung Chun; Gabriel Pineda; Sheldon R Morris; Cayla N Mason; Ifat Geron; Christian Barrett; Daniel J Goff; Russell Wall; Maurizio Pellecchia; Mark Minden; Kelly A Frazer; Marco A Marra; Leslie A Crews; Qingfei Jiang; Catriona H M Jamieson
Journal:  Cell Stem Cell       Date:  2016-06-09       Impact factor: 24.633

6.  Reduced adenosine-to-inosine miR-455-5p editing promotes melanoma growth and metastasis.

Authors:  Einav Shoshan; Aaron K Mobley; Russell R Braeuer; Takafumi Kamiya; Li Huang; Mayra E Vasquez; Ahmad Salameh; Ho Jeong Lee; Sun Jin Kim; Cristina Ivan; Guermarie Velazquez-Torres; Ka Ming Nip; Kelsey Zhu; Denise Brooks; Steven J M Jones; Inanc Birol; Maribel Mosqueda; Yu-ye Wen; Agda Karina Eterovic; Anil K Sood; Patrick Hwu; Jeffrey E Gershenwald; A Gordon Robertson; George A Calin; Gal Markel; Isaiah J Fidler; Menashe Bar-Eli
Journal:  Nat Cell Biol       Date:  2015-02-16       Impact factor: 28.824

Review 7.  Revealing protein-lncRNA interaction.

Authors:  Fabrizio Ferrè; Alessio Colantoni; Manuela Helmer-Citterich
Journal:  Brief Bioinform       Date:  2015-06-02       Impact factor: 11.622

8.  H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b.

Authors:  Constance Vennin; Nathalie Spruyt; Fatima Dahmani; Sylvain Julien; François Bertucci; Pascal Finetti; Thierry Chassat; Roland P Bourette; Xuefen Le Bourhis; Eric Adriaenssens
Journal:  Oncotarget       Date:  2015-10-06

9.  Integrative genomic analyses reveal clinically relevant long noncoding RNAs in human cancer.

Authors:  Zhou Du; Teng Fei; Roel G W Verhaak; Zhen Su; Yong Zhang; Myles Brown; Yiwen Chen; X Shirley Liu
Journal:  Nat Struct Mol Biol       Date:  2013-06-02       Impact factor: 15.369

10.  Computational prediction of microRNA networks incorporating environmental toxicity and disease etiology.

Authors:  Jie Li; Zengrui Wu; Feixiong Cheng; Weihua Li; Guixia Liu; Yun Tang
Journal:  Sci Rep       Date:  2014-07-04       Impact factor: 4.379

View more
  519 in total

1.  SITC cancer immunotherapy resource document: a compass in the land of biomarker discovery.

Authors:  Siwen Hu-Lieskovan; Srabani Bhaumik; Kavita Dhodapkar; Jean-Charles J B Grivel; Sumati Gupta; Brent A Hanks; Sylvia Janetzki; Thomas O Kleen; Yoshinobu Koguchi; Amanda W Lund; Cristina Maccalli; Yolanda D Mahnke; Ruslan D Novosiadly; Senthamil R Selvan; Tasha Sims; Yingdong Zhao; Holden T Maecker
Journal:  J Immunother Cancer       Date:  2020-12       Impact factor: 13.751

2.  The long noncoding RNA MALAT1 predicts human pancreatic islet isolation quality.

Authors:  Wilson Km Wong; Guozhi Jiang; Anja E Sørensen; Yi Vee Chew; Cody Lee-Maynard; David Liuwantara; Lindy Williams; Philip J O'Connell; Louise T Dalgaard; Ronald C Ma; Wayne J Hawthorne; Mugdha V Joglekar; Anandwardhan A Hardikar
Journal:  JCI Insight       Date:  2019-07-30

Review 3.  Epidrugs: targeting epigenetic marks in cancer treatment.

Authors:  Cristiana Libardi Miranda Furtado; Maria Claudia Dos Santos Luciano; Renan Da Silva Santos; Gilvan Pessoa Furtado; Manoel Odorico Moraes; Claudia Pessoa
Journal:  Epigenetics       Date:  2019-07-13       Impact factor: 4.528

Review 4.  Understanding the mechanistic basis of non-coding RNA through molecular dynamics simulations.

Authors:  Giulia Palermo; Lorenzo Casalino; Alessandra Magistrato; J Andrew McCammon
Journal:  J Struct Biol       Date:  2019-03-15       Impact factor: 2.867

5.  Integrative analysis of differential circular RNA and long non-coding RNA profiles and associated competing endogenous RNA networks in esophageal squamous cell carcinoma.

Authors:  Jiang-Feng Shen; Jin-Feng Ge; Shi-Ying Zheng; Dong Jiang
Journal:  Funct Integr Genomics       Date:  2021-01-07       Impact factor: 3.410

Review 6.  RNA-biology ruling cancer progression? Focus on 3'UTRs and splicing.

Authors:  Ayse Elif Erson-Bensan
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

Review 7.  Emerging roles of long non-coding RNAs in cancer.

Authors:  Manjima Chatterjee; Sonali Sengupta
Journal:  J Biosci       Date:  2019-03       Impact factor: 1.826

8.  MEG8 long noncoding RNA contributes to epigenetic progression of the epithelial-mesenchymal transition of lung and pancreatic cancer cells.

Authors:  Minoru Terashima; Akihiko Ishimura; Sasithorn Wanna-Udom; Takeshi Suzuki
Journal:  J Biol Chem       Date:  2018-09-27       Impact factor: 5.157

Review 9.  Circular RNAs in digestive system cancer: potential biomarkers and therapeutic targets.

Authors:  Jia-Qi Sheng; Lian Liu; Mu-Ru Wang; Pei-Yuan Li
Journal:  Am J Cancer Res       Date:  2018-07-01       Impact factor: 6.166

10.  Panel of potential lncRNA biomarkers can distinguish various types of liver malignant and benign tumors.

Authors:  Olga Y Burenina; Natalia L Lazarevich; Inna F Kustova; Daria A Shavochkina; Ekaterina A Moroz; Nikolay E Kudashkin; Yuriy I Patyutko; Alexey V Metelin; Eduard F Kim; Dmitry A Skvortsov; Timofei S Zatsepin; Maria P Rubtsova; Olga A Dontsova
Journal:  J Cancer Res Clin Oncol       Date:  2020-09-12       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.